Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials-Reference-Cited by-同舟云学术

Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials

Published:2019-11 Issue:10210 Volume:394 Page:1737-1749
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Virchow Johann Christian,Kuna Piotr,Paggiaro Pierluigi,Papi Alberto,Singh Dave,Corre Sandrine,Zuccaro Florence,Vele Andrea,Kots Maxim,Georges George,Petruzzelli Stefano,Canonica Giorgio Walter

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. GINA 2019: a fundamental change in asthma management: treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents;Reddel;Eur Respir J,2019

2. Use of long-acting β-agonists and inhaled steroids in asthma: meta-analysis of observational studies;Hirst;J Asthma,2010

3. Tiotropium in asthma poorly controlled with standard combination therapy;Kerstjens;N Engl J Med,2012

4. Long-term once-daily tiotropium respimat is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled study;Ohta;PLoS One,2015

5. Effects of the addition of tiotropium on airway dimensions in symptomatic asthma;Hoshino;Allergy Asthma Proc,2016

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

2. Therapeutic effect of long-acting muscarinic antagonist for treating uncontrolled asthma assessed using impulse oscillometry;Respiratory Research;2024-08-07

3. Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force;Journal of Investigational Allergology and Clinical Immunology;2024-07-30

4. Advances in inhaler therapy for asthma and chronic obstructive pulmonary disease: a comprehensive review of Fostair™ and Trimbow™;Journal of Pharmacy and Pharmacology;2024-07-02

5. Real-world characteristics of patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy in Japan;Respiratory Investigation;2024-07